Show simple item record

dc.contributor.authorTeo, Minyuen
dc.contributor.authorCrotty, Grace F
dc.contributor.authorO'Súilleabháin, Criostóir
dc.contributor.authorRidgway, Paul F
dc.contributor.authorConlon, Kevin C
dc.contributor.authorPower, Derek G
dc.contributor.authorMcDermott, Ray S
dc.date.accessioned2014-02-21T15:55:10Z
dc.date.available2014-02-21T15:55:10Z
dc.date.issued2013-03
dc.identifier.citationIdentification of distinct phenotypes of locally advanced pancreatic adenocarcinoma. 2013, 44 (1):73-8 J Gastrointest Canceren_GB
dc.identifier.issn1941-6636
dc.identifier.pmid22829058
dc.identifier.doi10.1007/s12029-012-9419-9
dc.identifier.urihttp://hdl.handle.net/10147/313211
dc.description.abstractA significant number of pancreatic ductal adenocarcinoma present as locally advanced disease. Optimal treatment remains controversial. We sought to analyze the clinical course of locally advanced pancreatic adenocarcinoma (LAPC) in order to identify potential distinct clinical phenotypes.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of gastrointestinal canceren_GB
dc.subject.meshAdenocarcinoma
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCombined Modality Therapy
dc.subject.meshDisease Progression
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Staging
dc.subject.meshPancreatic Neoplasms
dc.subject.meshPhenotype
dc.subject.meshPrognosis
dc.subject.meshProspective Studies
dc.subject.meshSurvival Rate
dc.titleIdentification of distinct phenotypes of locally advanced pancreatic adenocarcinoma.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Adelaide & Meath Hospital incorporating National Children's Hospital, Tallaght, Dublin, Ireland. neuy924@gmail.comen_GB
dc.identifier.journalJournal of gastrointestinal canceren_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
html.description.abstractA significant number of pancreatic ductal adenocarcinoma present as locally advanced disease. Optimal treatment remains controversial. We sought to analyze the clinical course of locally advanced pancreatic adenocarcinoma (LAPC) in order to identify potential distinct clinical phenotypes.


This item appears in the following Collection(s)

Show simple item record